Stem Cell Transplantation
Reduced-intensity SCT allows low toxicity, rapid engraftment from siblings
Published in Blood Weekly, May 22nd, 2003
According to D. Gomez-Almaguer and colleagues, "A group of 21 consecutive patients aged 4-20 (median 13) years was prospectively allografted using a reduced intensity preparative regimen. The group included both malignant (acute lymphoblastic leukemia, acute myelogenous leukemia, and chronic myelogenous leukemia) and nonmalignant (aplastic anemia, Diamond-Blackfan anemia, thalassemia major, and adrenoleukodystrophy) conditions. Follow-up times ranged between 16 and 1038 days."
The researchers reported graft-versus-host...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-05-22)
More Articles from Blood Weekly
- Hemochromatosis
What makes the body absorb too much iron? - Stem Cells
Researchers isolate protein needed for cell maintenance - Blood Safety
Pathogen reduction strategy reviewed - Hemostasis
Mathematical model quantitatively analyzes hemostasis during hemodilution - Leukemia
Prophylactic donor lymphocyte infusions seems to lower relapse risk after NST - Liver Regeneration
Transduced liver stem cells could treat gene-based liver diseases - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
